Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

MediciNova Inc

+ Add to Watchlist

MNOV:US

3.8200 USD 0.0600 1.55%

As of 20:10:00 ET on 05/01/2015.

Company Profile for MediciNova Inc (MNOV)

MediciNova, Inc. acquires, develops, and commercializes small molecule therapeutics. The Company, through alliances with Japanese pharmaceutical companies, has built a portfolio of drug candidates. MediciNova researches treatments for asthma, status asthmaticus, insomnia, interstitial cystitis, cancer, multiple sclerosis, preterm labor, urinary incontinence, and anxiety.

Contact Information

MediciNova Inc

4275 Executive Square
Suite 650
La Jolla, CA 92037
United States
Phone: 1-858-373-1500
Fax: 1-858-373-7000

Key Executives for MediciNova Inc (MNOV)

Yuichi IwakiPresident/CEO/FounderVan Den BoomChief Financial Officer
Kazuko MatsudaChief Medical OfficerMasatsune OkajimaVP/Head:Japanese Office
Geoffrey G O'BrienVice President

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil